4.6 Article

Improving risk-stratification of rheumatoid arthritis patients for interstitial lung disease

Related references

Note: Only part of the references are listed.
Article Medicine, General & Internal

Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease

Oliver Distler et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Article Medicine, General & Internal

Nintedanib in Progressive Fibrosing Interstitial Lung Diseases

K. R. Flaherty et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Article Medicine, General & Internal

MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease

P. -A. Juge et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Review Rheumatology

Mortality profile of patients with rheumatoid arthritis in France and its change in 10 years

Jerome Avouac et al.

SEMINARS IN ARTHRITIS AND RHEUMATISM (2017)

Article Critical Care Medicine

Interstitial lung disease in systemic sclerosis - A simple staging system

Nicole S. L. Goh et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)

Article Critical Care Medicine

A vicious circle of alveolar macrophages and fibroblasts perpetuates pulmonary fibrosis via CCL18

A Prasse et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)

Article Cardiac & Cardiovascular Systems

Role of KL-6 in evaluating the disease severity of rheumatoid lung disease: comparison with HRCT

F Kinoshita et al.

RESPIRATORY MEDICINE (2004)